LFWD Lifeward Ltd

ReWalk Robotics Ltd. (DBA Lifeward®) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, is pleased to announce that the Company has formally changed its name from ReWalk Robotics Ltd. to Lifeward Ltd. in completion of the rebranding initiative originally announced on January 29, 2024. The name change follows shareholder approval received on September 4, 2024, as well as the approval of the name change by the Israel Companies Registrar on September 10, 2024.

“We are pleased to have finalized this corporate rebrand so quickly after shareholder approval,” said Larry Jasinski, Chief Executive Officer at Lifeward. “The transformation of our corporate identity from ReWalk Robotics into Lifeward is reflective of the Company’s expanded mission to elevate the standard of care in overcoming physical limitations and disabilities and to empower individuals to do what they love.”

The Company’s subsidiaries in the United States and Germany have previously completed name changes earlier this year to align with the Lifeward brand. The Company’s trading symbol has also already been changed as part of the rebrand and will remain trading under "LFWD". Effective as of market open on September 13, 2024, the Company will begin trading under its new name.

About LifewardLifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.

Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.

Forward-Looking StatementsIn addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding Lifeward's future performance and future regulatory interactions and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K and 10-K/A for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Lifeward Media Relations:Kathleen O’DonnellVP Marketing & New Business DevelopmentLifewardE: media@golifeward.com

Lifeward Investor Contact:Mike LawlessChief Financial OfficerLifewardE: ir@golifeward.com